Hepatic colorectal metastases: methods of improving resectability

Area of Science:

• Hepatobiliary Surgery
• Surgical Oncology
• Gastroenterology

Background:

• Colorectal liver metastases (CLM) are a significant challenge in oncology.
• Surgical resection remains the most effective curative treatment for CLM.
• Many CLM are initially unresectable, limiting treatment options.

Purpose of the Study:

• To explore evolving definitions of resectability for CLM.
• To review strategies for converting unresectable CLM to a resectable state.
• To highlight the importance of multidisciplinary collaboration in managing CLM.

Main Methods:

• Neoadjuvant chemotherapy for downstaging unresectable tumors.
• Surgical techniques to enhance resectability (e.g., PVE, two-stage hepatectomy).
• Combination of resection with local ablative therapies (cryosurgery, radio-frequency ablation).

Main Results:

• Advanced surgical and neoadjuvant strategies can render initially unresectable CLM operable.
• Combined treatment modalities improve resectability rates and long-term survival.
• Techniques like portal vein embolization (PVE) and two-stage hepatectomy leverage liver regeneration.
• Local ablative therapies increase the pool of patients eligible for surgical intervention.

Conclusions:

• Surgical management of CLM has evolved, expanding options for initially unresectable cases.
• Multimodal approaches, including chemotherapy and advanced surgical techniques, offer curative potential.
• Close collaboration among oncologists, radiologists, and surgeons is crucial for optimal patient outcomes.
• Routine re-evaluation ensures timely and effective treatment sequencing for CLM patients.